Dewsbury Nathan - Volition Veterinary Diagnostics Development is a leading company based in Austin, TX, dedicated to revolutionizing the diagnosis and monitoring of life-altering diseases in both humans and animals. Their innovative family of Nu.Q tests, developed using patented Nucleosomics technology, detect characteristic changes in nucleosomes, enabling early detection and improved disease monitoring.
With a focus on innovation and a robust assay development pipeline, Dewsbury Nathan - Volition Veterinary Diagnostics Development is at the forefront of the cutting-edge field of epigenetics. Their diverse intellectual property portfolio, covering both human and veterinary applications, positions them as a significant player in the industry, with numerous patents granted and pending worldwide.
Generated from the website